Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NKD Pharma is a specialty pharmaceutical company based in the United Kingdom that focuses on the development, registration, and commercialization of generic and value-added medicines. The company targets niche therapeutic areas, particularly pain management, oncology, and central nervous system (CNS) disorders, aiming to provide cost-effective and improved treatment options. NKD Pharma utilizes a collaborative business model, partnering with global manufacturers and distributors to bring its product portfolio to international markets. Their expertise lies in navigating complex regulatory environments and optimizing drug formulations for better patient outcomes. By focusing on value-added medicines, the company seeks to repurpose or reformulate established molecules to address specific unmet clinical needs. The organization maintains a lean structure while leveraging a robust network of strategic alliances for manufacturing and supply chain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NKD Pharma.